News Releases

Einstein Celebrates Its 65th Commencement
A Novel Strategy For Treating Relapsed Blood Cancer
Einstein Represented in Two Key Roles at National Board of Medical Examiners

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Vilma Gabbay

Vilma Gabbay, M.D.

Area(s) of expertise: Pediatric anxiety & mood disordersAdolescent depression & suicideBiology of depression/neuroinflammation

Vilma Gabbay, Ph.D., is one of the nation’s leading experts on pediatric mood and anxiety disorders. She has received numerous federal grants to study a range of subjects, including neuroinflammation, teenage anhedonia (inability to feel pleasure), and brain systems related… Learn more

Einstein in the News

Science Friday
Rethinking The Future Of Dementia Care

Tia Powell, M.D., discusses the stigma that often surrounds a diagnosis of dementia, ways to improve dementia care, and the importance of supporting patient caregivers. Dr. Powell is professor of epidemiolgy & population health, the Dr. Shoshanah Trachtenberg Frackman Faculty Scholar in Biomedical Ethics, and director of the Montefiore Einstein Center for Bioethics.

More coverage on Dr. Powell

Bullying Doesn't Look Like it Used To. Experts Share How to Fix It

Hina Talib, M.D., comments on a study showing an association between bullying and suicidal ideation, and discusses ways to help the bully, the victim, and those who witness bullying. Dr. Talib is clinical associate professor of pediatrics at Einstein.

More coverage on Dr. Talib

Buprenorphine For Chronic Pain, Not Full Agonist Opioids, New VA Guidance Says

Joanna Starrels, M.D., M.S., co-authors an editorial on new guidelines on the use of buprenorphine, rather than other opioids, in chronic pain management. Dr. Starrels is professor of medicine and of psychiatry and behavioral sciences at Einstein, and associate chief of research in the division of general internal medicine and director of the IMPOWR-ME Research Center at Einstein and Montefiore.

More coverage on Dr. Starrels


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos